comparemela.com

Latest Breaking News On - Attention biotech investors - Page 7 : comparemela.com

(HRTX), Pacira Pharmaceuticals, Inc (NASDAQ:PCRX) - Heron s Non-Opioid, Post-Operative Pain Drug Approved By FDA: Why This Is Important

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ARCA biopharma, Inc (NASDAQ:ABIO) - The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

Second Sight Medical Products (NYSE:EYES), (LHDX) - Why Second Sight Medical, Lucira Health, RA Medical Are Moving Today

Amazon, Inc. (NASDAQ: AMZN) in the US. Each test kit, according to the company, provides a PCR quality test result at home in 30 minutes or less. After testing, users can also receive a free, text-based digital LUCI PASS verified test result on their phone for work or travel. The product costs $55 and includes free standard shipping. Lucira focuses on developing and commercializing infectious disease test kits. Lucira shares were rallying 17.09% to $5.96. Ra Medical Jumps: Medical device company Ra Medical reported a narrower-than-expected loss of $2.48 million and better-than-expected revenues of $1.1 million for the first quarter. The company, which commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases, noted an improvement in dermatology revenues, as COVID-19 restrictions are lifted.

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ARCA biopharma, Inc (NASDAQ:ABIO) - The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme s Clinical Trial Setback, 2 IPOs

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ARCA biopharma, Inc (NASDAQ:ABIO) - The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme s Clinical Trial Setback, 2 IPOs
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.